Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Junghanss, Christian  [Clear All Filters]
2023
Niederwieser D, Lang T, Krahl R, Heinicke T, Maschmeyer G, Al-Ali HKathrin, Schwind S, Jentzsch M, Cross M, Kahl C, et al. Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study. Ann Hematol. 2023.
2019
Saussele S, Haverkamp W, Lang F, Koschmieder S, Kiani A, Jentsch-Ullrich K, Stegelmann F, Pfeifer H, La Rosée P, Goekbuget N, et al. Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management. Acta Haematol. 2019:1-15.
2018
Heckl BChristine, Carlet M, Vick B, Roolf C, Alsadeq A, Grunert M, Liu W-H, Liebl A, Hiddemann W, Marschalek R, et al. Frequent and reliable engraftment of certain adult primary acute lymphoblastic leukemias in mice. Leuk Lymphoma. 2018:1-4.
2016
Peters S, Junghanss C, Knueppel A, Escobar HMurua, Roolf C, Knuebel G, Sekora A, Lindner I, Jonas L, Freund M, et al. Kinetics of Langerhans cell chimerism in the skin of dogs following 2 Gy TBI allogeneic hematopoietic stem cell transplantation. BMC Hematol. 2016;16:11.
Lange S, Steder A, Glass Ä, Killian D, Wittmann S, Machka C, Werner J, Schäfer S, Roolf C, Junghanss C. Low radiation dose and low cell dose increase the risk of graft rejection in a canine hematopoietic stem cell transplantation model. Biol Blood Marrow Transplant. 2016.
2015
Liu W, Moulay M, Willenbrock S, Roolf C, Junghanss C, Ngenazahayo A, Nolte I, Escobar HMurua. Comparative Characterization of Stem Cell Marker Expression, Metabolic Activity and Resistance to Doxorubicin in Adherent and Spheroid Cells Derived from the Canine Prostate Adenocarcinoma Cell Line CT1258. Anticancer Res. 2015;35(4):1917-27.